Cargando…
Opsoclonus myoclonus ataxia syndrome, ovarian teratoma and anti-NMDAR antibody: an ‘unresolved’ mystery
BACKGROUND: Opsoclonus–myoclonus–ataxia syndrome (OMAS) is characterised by the combination of opsoclonus and arrhythmic action myoclonus with axial ataxia and dysarthria. In adults, a majority are paraneoplastic secondary to solid organ tumours and could harbour antibodies against intracellular epi...
Autores principales: | Miraclin, Angel T, Mani, Arun Mathai, Sivadasan, Ajith, Nair, Aditya, Christina, Munagapati, Gojer, Abigail Ruth, Milton, Sharon, Jude Prakash, John A, Benjamin, Rohit N, Prabhakar, Appaswamy Thirumal, Mathew, Vivek, Aaron, Sanjith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314564/ https://www.ncbi.nlm.nih.gov/pubmed/37396795 http://dx.doi.org/10.1136/bmjno-2023-000414 |
Ejemplares similares
-
Ataxia as Forme Fruste of Opsoclonus Myoclonus Ataxia Syndrome
por: Dhawan, Sumeet R., et al.
Publicado: (2020) -
Opsoclonus-myoclonus-ataxia syndrome in an AIDS patient
por: Vale, Thiago Cardoso, et al.
Publicado: (2013) -
Opsoclonus–myoclonus–ataxia syndrome in an HIV-infected child
por: Pereira, Noella Maria Delia, et al.
Publicado: (2016) -
Delayed Opsoclonus–Myoclonus Syndrome After Ovarian Teratoma Resection
por: Jones, Andrea A., et al.
Publicado: (2022) -
Opsoclonus myoclonus ataxia syndrome following COVID-19 infection
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2022)